Inhalation Sciences receives order worth approx. 3 MSEK from leading big pharma company
(Stockholm December 11, 2019) Inhalation Sciences (ISAB) has received an order for a PreciseInhale aerosol R&D system with an intratracheal exposure module, a Nose-Only exposure module and ISAB’s leading in vitro simulation module DissolvIt. The total purchase order is worth 317,000 USD or 2992k SEK (current currency conversion rate).The order comes from a leading pharmaceutical company, and is their first order placed with Inhalation Sciences. The buyer has an extensive pipeline and this PreciseInhale-system is planned to be used at one of the company’s US-based affiliates. With this